Factors Associated With in Suboptimal Prescribing for Older Patients With Epilepsy
NCT00144001 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9682
Last updated 2015-04-07
Summary
Nearly 2% of veterans \>65 are actively treated for epilepsy, and the incidence is projected to increase with the aging of our society. Since commonly used antiepileptic drugs are considered suboptimal for older patients, it is important to understand existing patterns of treatment for older veterans with epilepsy.
Conditions
Sponsors & Collaborators
-
US Department of Veterans Affairs
lead FED
Principal Investigators
-
Mary Jo Pugh, PhD RN · South Texas Health Care System, San Antonio, TX
Eligibility
- Min Age
- 66 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-10-31
- Primary Completion
- 2004-09-30
- Completion
- 2008-09-30
Countries
- United States
Study Locations
More Related Trials
-
Tolerability and Efficacy of Depakote-extended Release in the Elderly
NCT00318929 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular Risk Reduction in Epilepsy
NCT05704439 ·Status: WITHDRAWN ·Phase: NA
-
Standardization of Anti-Seizure Medications Withdrawals After Seizure Remission in Young Patients With Epilepsy
NCT05740423 ·Status: UNKNOWN
-
Cognitive Impact of Benzodiazepin Withdrawn After Curative Epilepsy Surgery in Children With Focal Epilepsy
NCT03803046 ·Status: TERMINATED
-
Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database
NCT01390909 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy
NCT03083665 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.
NCT00141414 ·Status: COMPLETED ·Phase: PHASE2
-
Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy
NCT07193277 ·Status: RECRUITING ·Phase: PHASE4
-
Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy
NCT00043914 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy
NCT00236730 ·Status: COMPLETED ·Phase: PHASE2
-
Enhancing Antiepileptic Drug Adherence
NCT02165306 ·Status: COMPLETED ·Phase: NA
-
Adherence to Pharmacological Antiepileptic Treatment in Adolescence
NCT05825807 ·Status: UNKNOWN
-
This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment
NCT00150800 ·Status: COMPLETED ·Phase: PHASE3
-
Comorbidities of Epilepsy
NCT04106284 ·Status: UNKNOWN
-
Antiepileptic Drugs in Elderly Patients
NCT05459597 ·Status: RECRUITING
-
Novel Network Analysis of Intracranial Stereoelectroencephalography
NCT03916848 ·Status: UNKNOWN ·Phase: NA
-
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.
NCT00236691 ·Status: COMPLETED ·Phase: PHASE2
-
The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children
NCT05697614 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.
NCT00236873 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures
NCT00236860 ·Status: COMPLETED ·Phase: PHASE2
-
Psychiatric Comorbidities in Children With Generalized Epilepsy
NCT06194422 ·Status: NOT_YET_RECRUITING
-
Seizures and Traumatic Brain Injury Rehabilitation
NCT05823168 ·Status: COMPLETED
-
A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures
NCT00699283 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of the Incidence of Psychiatric Disorders As a Function of First-line Antiepileptic Drug Prescribing Practices: Use of Assurance Maladie Databases
NCT06829693 ·Status: NOT_YET_RECRUITING
-
Pharmacodynamics of Nasal and Buccal Midazolam Using EEG
NCT01316445 ·Status: TERMINATED ·Phase: PHASE1